Graduate School of Medical Science and Engineering, KAIST, Daejeon, Korea.
Yonsei Med J. 2011 Nov;52(6):871-8. doi: 10.3349/ymj.2011.52.6.871.
Hepatitis C virus (HCV), a non-cytopathic positive-stranded RNA virus, is one of the most common causes of chronic liver diseases such as chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Upon HCV infection, the majority of patients fail to clear the virus and progress to chronic hepatitis C. Chemokines are small chemotactic cytokines that direct the recruitment of immune cells and coordinate immune responses upon viral infection. Chemokine production during acute HCV infection contributes to the recruitment of immune cells with antiviral effector functions and subsequent viral clearance. In chronic HCV infection, however, continuous production of chemokines due to persistent viral replication might result in incessant recruitment of inflammatory cells to the liver, giving rise to persistence of chronic inflammation and liver injury. In this review, we will summarize the roles of chemokines in acute and chronic settings of HCV infection and the clinical relevance of chemokines in the treatment of hepatitis C.
丙型肝炎病毒(HCV)是一种非细胞病变的正链 RNA 病毒,是导致慢性肝脏疾病(如慢性肝炎、肝硬化和肝细胞癌)的最常见原因之一。HCV 感染后,大多数患者无法清除病毒,进展为慢性丙型肝炎。趋化因子是小分子趋化细胞因子,可在病毒感染时募集免疫细胞并协调免疫反应。急性 HCV 感染时趋化因子的产生有助于招募具有抗病毒效应功能的免疫细胞,进而清除病毒。然而,在慢性 HCV 感染中,由于持续的病毒复制导致趋化因子的持续产生,可能会导致炎症细胞不断浸润肝脏,引起慢性炎症和肝损伤的持续存在。在本综述中,我们将总结趋化因子在 HCV 感染的急性和慢性环境中的作用,以及趋化因子在治疗丙型肝炎方面的临床相关性。